Showing posts with label what is synthetic biology. Show all posts
Showing posts with label what is synthetic biology. Show all posts

Monday, 21 October 2019

The growing applications of synthetic biology is a major driver for the growth of this market.

 In this report, the market is segmented by tool, technology, application, and region. On the basis tool, the synthetic biology market is segmented into oligonucleotidesenzymescloning technology kits, chassis organisms, and xeno-nucleic acids. The chassis organisms segment is expected to grow at the highest rate during the forecast period. The increasing demand for green alternatives (biomass is converted to chemicals using engineered bacteria, yeasts, and other microorganisms) to fossil fuels is a key driver for this segment.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889



Some of The Major Players In Synthetic Biology Market:
1. Thermo Fisher (US)

2. Novozymes (Denmark)
3. Merck KGaA (Germany)
4. Intrexon (US)
5. Agilent Technologies (US)
5. Amyris (US)
6. GenScript (US)
7. Ginkgo Bioworks (US)
8. DNA Technologies (US)

According to the new market research report “Synthetic Biology Market” by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022", published by MarketsandMarkets™, The synthetic biology market is expected to reach USD 8.84 Billion by 2022 from an estimated USD 3.57 Billion in 2017, at a CAGR of 19.9%.

Get Sample Copy of This Report
@https://www.marketsandmarkets.com/requestsampleNew.asp?id=889

Synthetic Biology Market segmented into :

+ The global synthetic biology market is segmented on the basis of tool, technology, application, and region. Based on tools, the market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids.

+ By technology, the market is segmented into gene synthesis, genome engineering, cloning and sequencing, next-generation sequencing, site-directed mutagenesis, measurement and modeling, microfluidics, and nanotechnology.

+ The market is segmented into medical (pharmaceutical, drug discovery & therapeutics, and artificial tissue and tissue regeneration), industrial (biofuel & renewable energy, industrial enzymes, and biomaterials & green chemicals), food & agriculture, and environmental (bioremediation and biosensing) on the basis of application.

Want Full Report? Inquire Herehttps://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=889

Thursday, 10 October 2019

The growing applications of synthetic biology is a major driver for the growth of market.

Synthetic biology has an array of applications in the fields of medicine, agriculture, nanotechnology, and industrial biotechnology. This has attracted interests of researchers from across the globe and has led to a rise in funding from public and private organizations, which, in turn, help in the growth of the market.

Get Sample Copy of This Report
@https://www.marketsandmarkets.com/requestsampleNew.asp?id=889

Some of The Major Players In Synthetic Biology Market:
1. Thermo Fisher (US)
2. Novozymes (Denmark)
3. Merck KGaA (Germany)
4. Intrexon (US)
5. Agilent Technologies (US)
5. Amyris (US)
6. GenScript (US)
7. Ginkgo Bioworks (US)
8. DNA Technologies (US)

Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889

* Synthetic biology can broadly be described as the engineering and design of new biological parts and functions such as artificial biological pathways and organisms, which can further be used to produce end-products such as biofuels, biosensors, etc. Synthetic biology also includes the redesign of natural biological systems.

* The global synthetic biology market is segmented on the basis of tool, technology, application, and region. Based on tools, the market is segmented into oligonucleotides, enzymescloning technology kitschassis organisms, and xeno-nucleic acids. In 2017, oligonucleotides are expected to account for the largest share of the global market owing to the large-scale production of modified oligonucleotides for next-generation sequencing and the increasing market demand for synthetic genes.

Want Full Report? Inquire Here: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=889